πŸ•΅οΈ Agios Pharmaceuticals, Inc. ($AGIO)

SEC insider & ownership activity, last 12 months Β· CIK 1439222 Β· every row links its SEC filing

Over the last 12 months insiders sold $4.9M with no open-market buying against it. Goff Brian sold $1.7M through a 10b5-1 trading plan in 7 lots (Dec–Apr). No red-flag 8-Ks in the window.

🚨 1 signal active β€” planned-vs-executed verdicts, pre-event flags, and cluster context live in the API and the alerts bot.
Oct 2025: net -$162K Nov 2025: net -$116K Dec 2025: net -$824K Jan 2026: net -$78K Feb 2026: net +$0 Mar 2026: net -$1.3M Apr 2026: net -$1.2M May 2026: net +$0 Jun 2026: net +$0 Jul 2026: net -$151K Aug 2026: net -$914K Sep 2026: net +$0
Monthly net open-market insider flow, last 12 months (up = net buying)

Insider flow

0 buyers, $0 (0 lots) Β· 8 sellers, $4.9M (44 lots)

InsiderBuysBoughtSellsSoldLast
Goff Brian0– 7$1.7MApr 2, 2026
Gheuens Sarah0– 10$1.6MAug 4, 2026
Jones Cecilia0– 7$469KApr 2, 2026
Milanova Tsveta0– 5$353KApr 2, 2026
Burns James William0– 6$344KApr 2, 2026
Washburn Theodore James Jr.0– 4$217KMar 3, 2026
Viswanadhan Krishnan0– 2$185KApr 2, 2026
Scadden David0– 3$25KNov 12, 2025

5%+ holders

HolderStakeClassScheduleEvent
Farallon Capital Management, L.L.C. 9.9% 13GAug 3, 2026 filing β†—
Joshua J. Dapice 9.9% 13GAug 3, 2026 filing β†—
Dreyfuss, Philip D. 9.9% 13GAug 3, 2026 filing β†—
Hannah E. Dunn 9.9% 13GAug 3, 2026 filing β†—
Gehani, Varun N. 9.9% 13GAug 3, 2026 filing β†—
Giauque, Nicolas 9.9% 13GAug 3, 2026 filing β†—
Husen, Avner A. 9.9% 13GAug 3, 2026 filing β†—
KIM, David T. 9.9% 13GAug 3, 2026 filing β†—
LINN, Michael G. 9.9% 13GAug 3, 2026 filing β†—
LUO Patrick (CHENG) 9.9% 13GAug 3, 2026 filing β†—
Roberts, JR., Thomas G. 9.9% 13GAug 3, 2026 filing β†—
Edric C. Saito 9.9% 13GAug 3, 2026 filing β†—
Daniel S. Short 9.9% 13GAug 3, 2026 filing β†—
Spokes, Andrew J. M. 9.9% 13GAug 3, 2026 filing β†—
Warren, JOHN R. 9.9% 13GAug 3, 2026 filing β†—
Wehrly, MARK C. 9.9% 13GAug 3, 2026 filing β†—
BlackRock, Inc. 7.8% 13GJul 17, 2025 filing β†—
State Street Corporation 5.3% 13GFeb 9, 2026 filing β†—
Vanguard Capital Management 5.3% 13GApr 29, 2026 filing β†—
D. E. SHAW & Co., L.P. 5.1% 13GJul 2, 2026 filing β†—
David E. Shaw 5.1% 13GJul 2, 2026 filing β†—
LYNX1 Capital Management LP 5.1% 13GMay 6, 2026 filing β†—
Weston Nichols 5.1% 13GMay 6, 2026 filing β†—

Planned insider sales (Form 144)

SellerPlannedApprox. sale date
Sarah Gheuens$914KAug 4, 2026 filing β†—
Gheuens Sarah$151KJul 1, 2026 filing β†—
Goff Brian$652KApr 2, 2026 filing β†—
Jones Cecilia$107KApr 2, 2026 filing β†—
Viswanadhan Krishnan$101KApr 2, 2026 filing β†—
Milanova Tsveta$112KApr 2, 2026 filing β†—
Gheuens Sarah$101KApr 2, 2026 filing β†—
Burns James William$112KApr 2, 2026 filing β†—
Viswanadhan Krishnan$86KMar 5, 2026 filing β†—
Goff Brian$546KMar 2, 2026 filing β†—
Burns James William$158KMar 2, 2026 filing β†—
Gheuens Sarah$123KMar 2, 2026 filing β†—
Jones Cecilia$152KMar 2, 2026 filing β†—
Milanova Tsveta$87KMar 2, 2026 filing β†—
Milanova Tsveta$78KJan 5, 2026 filing β†—
Goff Brian$508KDec 30, 2025 filing β†—
Gheuens Sarah$80KDec 30, 2025 filing β†—
Jones Cecilia$80KDec 30, 2025 filing β†—
Milanova Tsveta$80KDec 30, 2025 filing β†—
Burns James William$80KDec 30, 2025 filing β†—
Sarah Gheuens$107KNov 11, 2025 filing β†—
Sarah Gheuens$9KOct 30, 2025 filing β†—
Sarah Gheuens$145KOct 27, 2025 filing β†—
David Scadden$8KOct 8, 2025 filing β†—
David Scadden$8KSep 30, 2025 filing β†—
Jones Cecilia$134KSep 26, 2025 filing β†—

Material events (8-K)

ItemEvent date
Earnings (2.02)Jul 30, 2026 filing β†—
Financial Statements and Exhibits (9.01)Jul 30, 2026 filing β†—
Officer/director changes (5.02)Jun 18, 2026 filing β†—
Shareholder vote (5.07)Jun 18, 2026 filing β†—
Financial Statements and Exhibits (9.01)Jun 18, 2026 filing β†—
Earnings (2.02)Apr 29, 2026 filing β†—
Financial Statements and Exhibits (9.01)Apr 29, 2026 filing β†—
Earnings (2.02)Feb 12, 2026 filing β†—
Financial Statements and Exhibits (9.01)Feb 12, 2026 filing β†—
Reg FD disclosure (7.01)Jan 12, 2026 filing β†—
Financial Statements and Exhibits (9.01)Jan 12, 2026 filing β†—
Earnings (2.02)Oct 30, 2025 filing β†—
Financial Statements and Exhibits (9.01)Oct 30, 2025 filing β†—